NEW YORK (GenomeWeb News) - Tm Bioscience today said it may be looking for a buyer or merger partner as one of several “strategic alternatives” it is exploring.
The company said it has formed a committee to look into its market potential and merger opportunities, although it added that it had not yet made any decisions to enter any transactions and that it will not list the names of potential partners.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.